Stock Market News1 month GILD’s Trodelvy Gets Second Breakthrough Therapy Tag for Lung Cancer Zacks
Gilead announces that the FDA grants a second Breakthrough Therapy designation to Trodelvy for the extensive-stage small cell lung cancer indication.
XGilead announces that the FDA grants a second Breakthrough Therapy designation to Trodelvy for the extensive-stage small cell lung cancer indication.
X